16 research outputs found

    Beta-alanine (Carnosyn™) supplementation in elderly subjects (60–80 years): effects on muscle carnosine content and physical capacity

    Get PDF
    The aim of this study was to investigate the effects of beta-alanine supplementation on exercise capacity and the muscle carnosine content in elderly subjects. Eighteen healthy elderly subjects (60–80 years, 10 female and 4 male) were randomly assigned to receive either beta-alanine (BA, n = 12) or placebo (PL, n = 6) for 12 weeks. The BA group received 3.2 g of beta-alanine per day (2 × 800 mg sustained-release Carnosyn™ tablets, given 2 times per day). The PL group received 2 × (2 × 800 mg) of a matched placebo. At baseline (PRE) and after 12 weeks (POST-12) of supplementation, assessments were made of the muscle carnosine content, anaerobic exercise capacity, muscle function, quality of life, physical activity and food intake. A significant increase in the muscle carnosine content of the gastrocnemius muscle was shown in the BA group (+85.4%) when compared with the PL group (+7.2%) (p = 0.004; ES: 1.21). The time-to-exhaustion in the constant-load submaximal test (i.e., TLIM) was significantly improved (p = 0.05; ES: 1.71) in the BA group (+36.5%) versus the PL group (+8.6%). Similarly, time-to-exhaustion in the incremental test was also significantly increased (p = 0.04; ES 1.03) following beta-alanine supplementation (+12.2%) when compared with placebo (+0.1%). Significant positive correlations were also shown between the relative change in the muscle carnosine content and the relative change in the time-to-exhaustion in the TLIM test (r = 0.62; p = 0.01) and in the incremental test (r = 0.48; p = 0.02). In summary, the current data indicate for the first time, that beta-alanine supplementation is effective in increasing the muscle carnosine content in healthy elderly subjects, with subsequent improvement in their exercise capacity

    Sistemas de preparo do solo e rotação de culturas na produtividade de milho, soja e trigo Tillage systems and crop rotation on yield of corn, soybean and wheat

    Get PDF
    Com este trabalho, objetivou-se determinar quanto os sistemas de preparo do solo e as rotações de culturas afetam a produtividade de grãos do milho, da soja e do trigo. O experimento foi conduzido em um Latossolo Vermelho distrófico, em área irrigada por pivô central, na EMBRAPA Arroz e Feijão, em Santo Antônio de Goiás, GO, por seis anos, setembro de 1992 a setembro de 1998, durante os quais foram feitos 12 cultivos e comparados três sistemas de preparo do solo: a) aração com arado de aiveca, realizada em novembro-dezembro e em maio-junho; b) aração com grade aradora, em ambos os períodos, e c) plantio direto e quatro rotações de cultura: 1) milho-feijão; 2) soja-trigo; 3) soja-trigo-soja-feijão-arroz-feijão e 4) milho-feijão-milho-feijão-arroz-feijão. As culturas de arroz, soja e milho, foram semeadas em novembro-dezembro e as de feijão e trigo, em maio-junho. Para efeito do estudo, consideraram-se somente as culturas do milho, da soja e do trigo. O sistema de preparo do solo não afetou a produtividade de soja mas, sim, a de milho e de trigo, tendo o preparo com arado propiciado maiores produtividades em comparação com o plantio direto. As diferenças entre o plantio direto e os demais sistemas de preparo do solo, com relação à produtividade acumulada relativa de milho, diminuíram com o tempo de cultivo. Não houve efeito da rotação de culturas sobre a produtividade das culturas estudadas.<br>The objective of this study was to determine how much soil tillage and crop rotation affected grain yield of corn, soybean and wheat. The study was carried out at EMBRAPA (Rice and Beans), in Santo Antônio de Goiás, GO, Brazil, in a Red Latosol (Oxisol), under center pivot irrigation system, for six consecutive years. During the experimentation, 12 crops were cultivated. The tillage treatments were a) moldboard plough, b) harrow disc and c) no-tillage. The crop rotations were 1) corn-bean, 2) soybean-wheat, 3) soybean-wheat-soybean-bean-upland rice-bean and 4) corn-bean-corn bean-upland rice-bean. Rice, soybean and corn were sown in November/December and bean and wheat in May/June. For this study, only corn, soybean and wheat were considered. Soil tillage affected corn and wheat yields but did not affect soybean yield. Corn and wheat yields under mouldboard plough were higher than under no-tillage. The differences among no-tillage and the other tillage systems in relation to relative accumulative corn yield decreased as the cultivation period increased. Crop rotations did not affect the crop yields

    Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

    No full text
    Objective To evaluate whether the addition of colchicine to standard treatment for COVID-19 results in better outcomes.Design We present the results of a randomised, double-blinded, placebo-controlled clinical trial of colchicine for the treatment of moderate to severe COVID-19, with 75 patients allocated 1:1 from 11 April to 30 August 2020. Colchicine regimen was 0.5 mg thrice daily for 5 days, then 0.5 mg twice daily for 5 days. The primary endpoints were the need for supplemental oxygen, time of hospitalisation, need for admission and length of stay in intensive care unit and death rate.Results Seventy-two patients (36 for placebo and 36 for colchicine) completed the study. Median (and IQR) time of need for supplemental oxygen was 4.0 (2.0–6.0) days for the colchicine group and 6.5 (4.0–9.0) days for the placebo group (p&lt;0.001). Median (IQR) time of hospitalisation was 7.0 (5.0–9.0) days for the colchicine group and 9.0 (7.0–12.0) days for the placebo group (p=0.003). At day 2, 67% versus 86% of patients maintained the need for supplemental oxygen, while at day 7, the values were 9% versus 42%, in the colchicine and the placebo groups, respectively (log rank; p=0.001). Two patients died, both in placebo group. Diarrhoea was more frequent in the colchicine group (p=0.26).Conclusion Colchicine reduced the length of both, supplemental oxygen therapy and hospitalisation. The drug was safe and well tolerated. Once death was an uncommon event, it is not possible to ensure that colchicine reduced mortality of COVID-19.Trial registration number RBR-8jyhxh
    corecore